OnabotulinumtoxinA Significantly Decreases Urinary Incontinence and Provides Treatment Benefit in Patients with Idiopathic Overactive Bladder

Chapple C1, Thompson C2, Nardo C2, Yan X2, Haag-Molkenteller C2

Abstract Category

Pharmacology: Clinical

Abstract 550
Non Discussion Poster
Scientific Non Discussion Poster Session 31
1. Royal Hallamshire Hospital, 2. Allergan LLC
Links

Abstract

18/04/2024 21:05:40